MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Opinions and clinical practices related to diagnosing and managing patients with functional (psychogenic) movement disorders: from 2009 to 2019

K. Lafaver, D. Bega, M. Hallett, A. Lang, S. Lidstone, C. Maurer, F. Morgante, D. Perez, C. Stephen, J. Stone, T. Teodoro, A. Wu, A. Dwivedi, A. Espay (Louisville, KY, USA)

Meeting: 2019 International Congress

Abstract Number: 395

Keywords: Psychogenic movement disorders(PMD): Clinical features, Psychogenic movement disorders(PMD): Etiology and Pathogenesis, Psychogenic movement disorders(PMD): Treatment

Session Information

Date: Monday, September 23, 2019

Session Title: Functional (Psychogenic) Movement Disorders

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: (1) To examine current opinion and clinical practices related to diagnosis and management of Functional Movement Disorders (FMD); and (2) to determine if practice patterns have changed compared to a similar survey to members of the International Parkinson and Movement Disorder Society (MDS) conducted ten years ago [1].

Background: FMD present common and unique challenges to practitioners. Gaps in knowledge include variability in the diagnostic approach, clinical management, and access to treatment around the world.

Method: A 21-item survey about attitudes and clinical practices regarding FMD used in a prior survey [1], updated by the MDS FMD Study group, was sent to MDS members. The survey remained open for six weeks between August 16 and September 28, 2018.

Results: There were 864 responses from MDS members in 92 countries, for an estimated response rate in practicing clinicians of 25.5%. Respondents were predominantly male (55%), under the age of 45 (65%), and worked in an academic practice setting (85%). Similar to 2009, a majority of respondents (46.7%) chose to order standard neurological investigations before informing a patient of a FMD diagnosis. Unlike the early survey, a significantly higher number informed patients about the diagnosis based on unequivocal features on exam alone (26.5% vs 18.9%; p=0.003). 63.5% of respondents were more concerned about missing another diagnosis in FMD patients compared to other disorders they manage. Avoiding iatrogenic harm (58.1%), educating the patient about the diagnosis (53.1%), referral to rehabilitation services (40.4%) and psychotherapy (34.6%) were believed to be most effective therapeutic options. Frequent treatment barriers varied between countries and included lack of physician knowledge and training (31.8%), lack of treatment guidelines (39.1%), availability of referral services (47.9%), and cultural beliefs about psychological illnesses (50.4%). Compared to 2009, the preferred term for communication with healthcare professionals and the lay public was “functional” rather than “psychogenic” (p<0.001).

Conclusion: While practices in diagnosis and treatment of FMD are slowly changing, an exclusionary approach to the diagnosis remains the norm. Limited access to treatment resources for FMD remains a major problem.

References: 1. Espay AJ, Goldenhar LM, Voon V, Schrag A, Burton N, Lang AE. Opinions and clinical practices related to diagnosing and managing patients with psychogenic movement disorders: An international survey of movement disorder society members. Movement disorders: official journal of the Movement Disorder Society 2009;24:1366-1374.

To cite this abstract in AMA style:

K. Lafaver, D. Bega, M. Hallett, A. Lang, S. Lidstone, C. Maurer, F. Morgante, D. Perez, C. Stephen, J. Stone, T. Teodoro, A. Wu, A. Dwivedi, A. Espay. Opinions and clinical practices related to diagnosing and managing patients with functional (psychogenic) movement disorders: from 2009 to 2019 [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/opinions-and-clinical-practices-related-to-diagnosing-and-managing-patients-with-functional-psychogenic-movement-disorders-from-2009-to-2019/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/opinions-and-clinical-practices-related-to-diagnosing-and-managing-patients-with-functional-psychogenic-movement-disorders-from-2009-to-2019/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley